UNSPSC 51144108: Amphetamine hydrochloride

This classification denotes a cns stimulant with the molecular formula C9H13N.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70DMY940ZG. Most nations, for tariff and trade purposes, schedule amphetamine hydrochloride under HS 29214600. As of Q4 2014, AMPHETAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Amphetamine hydrochloride bears US NLM identifiers UMLS ID C2698101 and NCI Concept Code C77844. SMILES: CC(CC1CCCCC1)N.CL.

UNSPSC 51144108 Amphetamine hydrochloride is a Commodity code that does not align with actual state and local procurement activity under this classification. The single recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems, products wholly unrelated to amphetamine hydrochloride manufacturing or supply. The mismatch suggests either a data-classification error in the issuing body's tagging or a misalignment between the code's nominal pharmaceutical scope and how state and local procurement systems are using it in practice. No state or local opportunities for amphetamine hydrochloride itself appear in the recent record.

The Seminole County opportunity, posted June 30, 2026, with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the county's Community Health Building in Sanford, Florida. Bids were required to include all shipping and delivery costs, with vendors subject to drug-free workplace certification, E-Verify compliance, and federal compliance requirements tied to potential FEMA funding. The contract provided an initial two-year term with a one-year renewal option. This code shows no meaningful recent state and local procurement activity aligned with its nominal commodity classification.